CompanyScope

Biogen Inc. revenue by year

Ticker BIIB · SEC CIK 875045 · Latest fiscal year ended Dec 31, 2025

Over the 10 fiscal years shown, revenue went from $11.45B (year ended Dec 31, 2016) to $9.89B (year ended Dec 31, 2025), a compound annual growth rate of -1.6%. The fastest growth was +9.6% in the year ended Dec 31, 2018; the weakest year was −18.3% (year ended Dec 31, 2021).

$0$5B$10B$15BDec 2016: $11.45BDec 2017: $12.27BDec 2018: $13.45BDec 2019: $14.38BDec 2020: $13.44BDec 2021: $10.98BDec 2022: $10.17BDec 2023: $9.84BDec 2024: $9.68BDec 2025: $9.89BDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Biogen Inc. revenue by fiscal year, USD. Hover a bar for the exact figure.

Annual revenue

Fiscal year endedRevenue (USD)ChangeXBRL conceptReported in
Dec 31, 2025$9.89B+2.2%Revenues10-K filed Feb 6, 2026
Dec 31, 2024$9.68B−1.6%Revenues10-K filed Feb 6, 2026
Dec 31, 2023$9.84B−3.3%Revenues10-K filed Feb 6, 2026
Dec 31, 2022$10.17B−7.4%Revenues10-K filed Feb 12, 2025
Dec 31, 2021$10.98B−18.3%Revenues10-K filed Feb 14, 2024
Dec 31, 2020$13.44B−6.5%Revenues10-K filed Feb 15, 2023
Dec 31, 2019$14.38B+6.9%Revenues10-K filed Feb 3, 2022
Dec 31, 2018$13.45B+9.6%Revenues10-K filed Feb 3, 2021
Dec 31, 2017$12.27B+7.2%Revenues10-K filed Feb 6, 2020
Dec 31, 2016$11.45B+6.4%Revenues10-K filed Feb 6, 2019

Quarterly revenue

Quarters reported in 10-Q filings. Fourth quarters are usually reported only inside the annual 10-K, so they are not listed separately here; we do not estimate them.

QuarterRevenue (USD)vs same quarter a year earlierSource
3 months ended Sep 30, 2026$2.80B+10.6%10-Q filed Oct 28, 2026
3 months ended Jun 30, 2026$2.74B+3.4%10-Q filed Jul 29, 2026
3 months ended Mar 31, 2026$2.48B+1.9%10-Q filed Apr 29, 2026
3 months ended Sep 30, 2025$2.53B+2.8%10-Q filed Oct 28, 2026
3 months ended Jun 30, 2025$2.65B+7.3%10-Q filed Jul 29, 2026
3 months ended Mar 31, 2025$2.43B+6.1%10-Q filed Apr 29, 2026
3 months ended Sep 30, 2024$2.47B−2.5%10-Q filed Oct 30, 2025
3 months ended Jun 30, 2024$2.46B+0.4%10-Q filed Jul 31, 2025

Source: SEC EDGAR XBRL company facts for CIK 875045 (raw data). Most recent filing in this dataset: 10-Q filed Oct 28, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.